QuantaLife, Inc. - A Bio-Rad Company

QuantaLife developed Droplet Digital(TM) PCR. Droplet Digital PCR provides an absolute measure of target molecules with unrivaled quantitative resolution and sensitivity. Applications include copy number variation (CNV), mutation detection, and gene expression analysis. Our mission is to provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. This technology is now a part of Bio-Rad Laboratories as the QX100 Droplet Digital PCR System. The original location of QuantaLife is now Bio-Rad's Digital Biology Center, where continual development of ddPCR technology is underway. Please follow the Bio-Rad Laboratories company page.